Bhavesh D. Patel
Bhavesh D. Patel has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Monika Jangid
Department of Chemistry, PAHER University, Udaipur, Rajasthan, India
1 shared publication - Nageswararao Pulakundam
Drug Metabolism Pharmacokinetics and Bioanalysis, Eurofins Advinus Biopharma Services India Pvt Ltd., 21 and 22, Phase II, Peenya Industrial Area, Bengaluru-560058, India. Department of Chemistry, PAHER University, Udaipur, Rajasthan, India
1 shared publication Naresh P.
Drug Metabolism Pharmacokinetics and Bioanalysis, Eurofins Advinus Biopharma Services India Pvt Ltd., 21 and 22, Phase II, Peenya Industrial Area, Bengaluru-560058, India
1 shared publication- Paras Tak
Department of Chemistry, PAHER University, Udaipur, Rajasthan, India
1 shared publication
Latest Publications
- Open Access
- 7 September 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 522-534
Bioanalytical Method Development and Validation for a Novel Secretory Phospholipase A₂ Inhibitor by LC-MS/MS and its Application to a Pharmacokinetic Study in Mice
Objective: This study aimed to develop and validate a sensitive LC–MS/MS method for quantifying a novel Secretory phospholipase A₂ (sPLA₂) inhibitor, compound-7(L), in mouse plasma and to evaluate its application in pharmacokinetic studies. Methods: A bioanalytical LC–MS/MS method was developed and validated according to ICH M10 guidelines. Compound-7(L) was extracted from mouse plasma using protein precipitation. Pharmacokinetic studies were conducted in male C57BL/6 mice following intravenous administration at a dose of 1 mg/kg. Results: The method was linear over the range of 0.100–100 ng/ml with regression coefficient>0.99. Intra-and Inter-run accuracy ranged from 89.67% to 105.00% and 90.00 % to100%, respectively. The intra-and inter-day precision values were1.88% to 9.52% and 0.30 % to 4.00%, respectively. All stability assessments were within acceptance criteria of ±15%. Conclusion: The method exhibits excellent specificity and selectivity, with well-fitted linearity over the validated concentration range. The established method, validated in line with ICH M10 guidelines, was shown to be accurate, precise, rugged, and stable in mouse plasma, meeting all specified acceptance criteria. Overall, the validated method, owing to its simplicity, sensitivity, and cost‑effectiveness, is suitable for mouse plasma analysis and supports its application in pharmacokinetic study.
- 7 September 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 522-534
Open AccessBioanalytical Method Development and Validation for a Novel Secretory Phospholipase A₂ Inhibitor by LC-MS/MS and its Application to a Pharmacokinetic Study in Mice
Objective: This study aimed to develop and validate a sensitive LC–MS/MS method for quantifying a novel Secretory phospholipase A₂ (sPLA₂) inhibitor, compound-7(L), in mouse plasma and to evaluate its application in pharmacokinetic studies. Methods: A bioanalytical LC–MS/MS method was developed and validated according to ICH M10 guidelines. Compound-7(L) was extracted from mouse plasma using protein precipitation. Pharmacokinetic studies were conducted in male C57BL/6 mice following intravenous administration at a dose of 1 mg/kg. Results: The method was linear over the range of 0.100–100 ng/ml with regression coefficient>0.99. Intra-and Inter-run accuracy ranged from 89.67% to 105.00% and 90.00 % to100%, respectively. The intra-and inter-day precision values were1.88% to 9.52% and 0.30 % to 4.00%, respectively. All stability assessments were within acceptance criteria of ±15%. Conclusion: The method exhibits excellent specificity and selectivity, with well-fitted linearity over the validated concentration range. The established method, validated in line with ICH M10 guidelines, was shown to be accurate, precise, rugged, and stable in mouse plasma, meeting all specified acceptance criteria. Overall, the validated method, owing to its simplicity, sensitivity, and cost‑effectiveness, is suitable for mouse plasma analysis and supports its application in pharmacokinetic study.